Transaction · 0000874015-26-000110

PARSHALL B LYNNE

PARSHALL B LYNNE, DIR, reported an open-market or private sale at IONIS PHARMACEUTICALS INC involving 5000.000000 shares for an estimated $413588.50. Reported holdings after the transaction were 56344.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
IONSIONIS PHARMACEUTICALS INC
Filing timeFeb 14
Trade dateFeb 11, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$80.59
Pre-filing
1mo ago +1.3%1w ago +5.5%1d ago +4.6%
Returns since
7d +3.2%30d -10.2%90d -7.9%180d -30.7%1y -20.7%

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2026-02-14Filed 201 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000874015-26-000110
Common Stock
Transaction date
Feb 11, 2026
Filed Feb 14, 2026, 12:40 AM · 3d delay
Shares
5.00k sh
$8.27k per share
Estimated value
-$41.3M
Computed from shares × price
Holdings after
56.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 6, 2025.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.585 to $82.97 inclusive. The reporting person undertakes to prov…

Original filing · 0000874015-26-000110
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS